Loading clinical trials...
Loading clinical trials...
The aim of the study is to investigate the effect of roflumilast (APTA-2217) on lung function in patients with asthma. Roflumilast will be administered orally once daily. The study duration consists o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
Collaborators
NCT07326995 · Bronchial Asthma
NCT07324707 · Bronchial Asthma
NCT06528418 · Lung Cancer, Lung Infection, and more
NCT06852911 · Bronchial Asthma, Airway Disease
NCT06624735 · Bronchial Asthma
Nycomed Japan and Mitsubishi Tanabe Pharma Corporation
Osaka
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions